The growth in research and development in 2020 was largely driven by new oncology drugs, new funding, and strategic investments – which all speak to the resilience and strength of the global biopharmaceutical industry.
This webinar follows the release of a new IQVIA Institute report on Global Trends in R&D: Overview through 2020 and is intended to generate meaningful discussion among a multi-stakeholder panel around timely topics related to R&D trends in 2020.
Speakers and panelists
The webinar will be moderated by Murray Aitken, Executive Director, the IQVIA Institute for Human Data Science. Speakers are:
- Amitabh Chandra, Professor of Business Administration at Harvard Business School and Director of Health Policy Research at Harvard Kennedy School of Government
- Cartier Esham, EVP, Emerging Companies & SVP, Science and Regulatory Affairs, Biotechnology Innovation Organization (BIO)
- Ken Getz, Director of the Tufts Center for the Study of Drug Development